Início › Câncer de Mama › Califórnia › Santa Monica
Ensaios clínicos de Câncer de Mama em Santa Monica, CA
28 estudos para Câncer de Mama estão buscando participantes em locais em Santa Monica e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RecrutandoFase 3
- Beverly Hills Cancer Center, Beverly Hills · a 6 mi de distância
A Study of PHST001 in Advanced Solid Tumors
RecrutandoFase 1
- Precision NextGen Oncology & Research Center, Beverly Hills · a 6 mi de distância
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RecrutandoFase 2
- Beverly Hills Cancer Center, Beverly Hills · a 6 mi de distância
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecrutandoFase 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Recrutando
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
RecrutandoFase 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · a 6 mi de distância
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RecrutandoFase 3
- Clinical Trial Site, Beverly Hills · a 6 mi de distância
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecrutandoFase 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecrutandoFase 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RecrutandoFase 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RecrutandoFase 1/2
- Beverly Hills Cancer Center, Beverly Hills · a 6 mi de distância
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RecrutandoFase 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecrutandoFase 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · a 6 mi de distância
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RecrutandoFase 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
RecrutandoFase 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecrutandoFase 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- e mais 1
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecrutandoFase 3
- Tower Cancer Research Foundation, Beverly Hills · a 6 mi de distância
- Cedars-Sinai Cancer - Tarzana, Tarzana · a 11 mi de distância
- Kaiser Permanente-Woodland Hills, Woodland Hills · a 12 mi de distância
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
RecrutandoFase 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · a 6 mi de distância
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
RecrutandoFase 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · a 11 mi de distância
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RecrutandoFase 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
RecrutandoFase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · a 12 mi de distância
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecrutandoFase 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · a 4 mi de distância
- Precision NextGen Oncology & Research Center, Beverly Hills · a 6 mi de distância
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecrutandoFase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RecrutandoFase 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecrutandoFase 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · a 11 mi de distância
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RecrutandoFase 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
RecrutandoEstudo observacional
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Ensaios de Câncer de Mama em outras cidades
- New York City, NY136 estudos
- Houston, TX126 estudos
- Boston, MA112 estudos
- Nashville, TN81 estudos
- Los Angeles, CA73 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Queens, NY64 estudos
- Durham, NC64 estudos
- Chicago, IL59 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Santa Monica
- Câncer de Pulmão de Não Pequenas Células45 estudos
- Câncer Colorretal23 estudos
- Câncer (todos os tipos)22 estudos
- Câncer Metastático19 estudos
- Câncer de Pulmão15 estudos
- Câncer de Ovário15 estudos
- Câncer de Próstata15 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço13 estudos
- Insuficiência Cardíaca11 estudos
- Câncer Endometrial10 estudos
- Câncer de Estômago9 estudos
- Câncer de Pâncreas9 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.